Author

Lily Zhang

h-index 4 View on Semantic Scholar

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Weight-Loss Outcomes After Sleeve Gastrectomy Versus Tirzepatide in a Minority Cohort With Severe Obesity: Results From a Propensity Score Matched Cohort.

While GLP-1 and GIP receptor agonists like semaglutide and tirzepatide have revolutionized pharmacologic obesity treatment, metabolic and bariatric surgery (MBS) continues to demonstrate superior weight loss and cost-effectiveness. Current evidence shows tirzepatide outperforms semaglutide with over 20% weight reductio...

E. G. Manueli Laos, Andres Fontaine-Nicola, Bianca Serafica et al. · Clinical Obesity · 0 citations

Open access Oct 2026

Neoadjuvant Chemo-Immunotherapy Yields Survival Comparable to Upfront Surgery in Metaplastic Breast Cancer: A National Cancer Database Analysis.

OBJECTIVE Metaplastic breast carcinoma (MpBC) is a rare and aggressive subtype of breast cancer, often characterized by triple-negative (TN) receptor status and a limited response to standard chemotherapy. The optimal treatment strategy remains undefined. This study evaluates overall survival (OS) in patients with TN-M...

M. Nelis, Lily Zhang, V. Gadi et al. · Annals of Surgical Oncology · 0 citations